Published in

Wiley, British Journal of Haematology, 5(192), p. 869-878, 2020

DOI: 10.1111/bjh.16980

Links

Tools

Export citation

Search in Google Scholar

Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open‐label Phase II study

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO